These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 23846864
21. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Circulation; 2006 Jul 11; 114(2):160-7. PubMed ID: 16818808 [Abstract] [Full Text] [Related]
22. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. J Am Coll Cardiol; 2011 Sep 20; 58(13):1343-50. PubMed ID: 21920263 [Abstract] [Full Text] [Related]
23. Lifestyle counseling in patients with hypertension in primary health care and its association with antihypertensive pharmacotherapy. Lindblom S, Ivarsson C, Wändell P, Bergqvist M, Norrman A, Eriksson J, Lund L, Hagströmer M, Hasselström J, Sandlund C, Carlsson AC. J Clin Hypertens (Greenwich); 2024 Jul 20; 26(7):816-824. PubMed ID: 38850281 [Abstract] [Full Text] [Related]
24. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox. Hermida RC, Ayala DE, Mojón A, Fernández JR. Chronobiol Int; 2013 Mar 20; 30(1-2):87-98. PubMed ID: 23039824 [Abstract] [Full Text] [Related]
25. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, Jousilahti P, Tuomilehto J. Hypertension; 2011 Jun 20; 57(6):1094-100. PubMed ID: 21536985 [Abstract] [Full Text] [Related]
26. Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients. Pierdomenico SD, Pierdomenico AM, Coccina F, Lapenna D, Porreca E. Am J Hypertens; 2016 Aug 20; 29(8):1001-7. PubMed ID: 26992413 [Abstract] [Full Text] [Related]
27. Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H. Intern Med J; 2013 Feb 20; 43(2):137-43. PubMed ID: 22909211 [Abstract] [Full Text] [Related]
28. The effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohort. Barengo NC, Antikainen R, Kastarinen M, Laatikainen T, Tuomilehto J. J Hum Hypertens; 2013 Nov 20; 27(11):693-7. PubMed ID: 23514844 [Abstract] [Full Text] [Related]
29. Compliance to antihypertensive drugs, salt restriction, exercise and control of systemic hypertension in hypertensive patients at Abbottabad. Ahmed N, Abdul Khaliq M, Shah SH, Anwar W. J Ayub Med Coll Abbottabad; 2008 Nov 20; 20(2):66-9. PubMed ID: 19385461 [Abstract] [Full Text] [Related]
30. Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort. Alam DS, Chowdhury MA, Siddiquee AT, Ahmed S, Niessen LW. BMJ Open; 2014 Dec 23; 4(12):e004983. PubMed ID: 25537780 [Abstract] [Full Text] [Related]
31. Cardiovascular outcomes of lifestyle intervention in hypertensive patients with antihypertensive agents. Hua K, Hao G, Li W. Int J Cardiol; 2017 Jan 15; 227():751-756. PubMed ID: 27810294 [Abstract] [Full Text] [Related]
32. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B, LIFE Study Investigators. Circulation; 2006 Jan 03; 113(1):67-73. PubMed ID: 16365195 [Abstract] [Full Text] [Related]
33. Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patients. Spoladore R, Roccaforte R, Fragasso G, Gardini C, Palloshi A, Cuko A, Arioli F, Salerno A, Margonato A. Acta Cardiol; 2009 Aug 03; 64(4):485-91. PubMed ID: 19725441 [Abstract] [Full Text] [Related]
34. ESH-ESC guidelines for the management of hypertension. Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B. Herz; 2006 Jun 03; 31(4):331-8. PubMed ID: 16810473 [Abstract] [Full Text] [Related]
35. Comparative study of cardiac autonomic status by heart rate variability between under-treatment normotensive and hypertensive known type 2 diabetics. Solanki JD, Basida SD, Mehta HB, Panjwani SJ, Gadhavi BP. Indian Heart J; 2017 Jun 03; 69(1):52-56. PubMed ID: 28228307 [Abstract] [Full Text] [Related]
36. Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland. Wang Y, Tuomilehto J, Jousilahti P, Salomaa V, Li B, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Heart; 2013 Feb 03; 99(3):163-7. PubMed ID: 23144292 [Abstract] [Full Text] [Related]
37. Do Hypertensive Individuals Who Are Aware of Their Disease Follow Lifestyle Recommendations Better than Those Who Are Not Aware? Kim Y, Kong KA. PLoS One; 2015 Feb 03; 10(8):e0136858. PubMed ID: 26317336 [Abstract] [Full Text] [Related]